pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·2h ago·1 min read
save

Endpoints Weekly returns with new class unveiled at Boston gala

Sep 26, 2026·read at Endpoints ↗Neutral

The newsletter marks the return of Endpoints Weekly, a regular briefing on pharmaceutical industry news.

The latest edition introduced the "Endpoints 11" cohort during a gala event in Boston, and readers are invited to view the class list or watch a replay of the presentation.

Access to the full article is limited to subscribers, with options to sign up for a free limited number of reads or upgrade to a premium subscription.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “The drug industry’s care gap; Novo aims to diversify; and more”

read at Endpoints ↗
86 words · retrieved 43m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVO

related stories

  • May 6STAT+: Oregon hospitals won’t outsource to national physician chain after allSTAT
  • May 6STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’STAT
  • May 6Novo hikes guidance on Wegovy pill’s fast sales startBioPharma Dive
  • May 6STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human diseaseSTAT
  • May 6STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share priceSTAT